Oric Pharmaceuticals, Inc. short interest in 2023
In 2023, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 9.70% of shares outstanding on 13 Jan 2023 to 15.95% on 29 Dec 2023, a change of +6.25 percentage points. The year's high was 16.36% on 30 Nov 2023 and its low 9.07% on 15 Mar 2023, averaging 11.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 42.01 days on 15 May 2023. Full history: Oric Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 9.70% (13 Jan 2023)
- End of year
- 15.95% (29 Dec 2023)
- Change
- +6.25 pp
- High
- 16.36% (30 Nov 2023)
- Low
- 9.07% (15 Mar 2023)
- Average
- 11.89%
- Highest days to cover
- 42.01 (15 May 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 9.70% | 7.24 | results (8-K) |
| 31 Jan 2023 | 10.80% | 15.13 | |
| 15 Feb 2023 | 10.48% | 18.00 | |
| 28 Feb 2023 | 10.48% | 27.72 | |
| 15 Mar 2023 | 9.07% | 36.86 | |
| 31 Mar 2023 | 9.24% | 15.27 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 9.41% | 28.22 | |
| 28 Apr 2023 | 9.40% | 27.95 | |
| 15 May 2023 | 9.49% | 42.01 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.57% | 40.26 | |
| 15 Jun 2023 | 11.02% | 14.08 | |
| 30 Jun 2023 | 13.17% | 4.64 | |
| 14 Jul 2023 | 13.18% | 24.00 | |
| 31 Jul 2023 | 12.91% | 18.99 | |
| 15 Aug 2023 | 10.81% | 21.78 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 11.18% | 27.19 | |
| 15 Sep 2023 | 11.43% | 21.48 | |
| 29 Sep 2023 | 12.59% | 12.95 | |
| 13 Oct 2023 | 13.20% | 13.08 | |
| 31 Oct 2023 | 13.99% | 14.29 | |
| 15 Nov 2023 | 16.08% | 18.62 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 16.36% | 28.95 | |
| 15 Dec 2023 | 15.89% | 18.59 | |
| 29 Dec 2023 | 15.95% | 34.08 |
See also: Oric Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.